Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1
Biochemical and Biophysical Research Communications · 2025
DOI: 10.1016/j.bbrc.2025.152194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von So Rae Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, South Korea. Hauptthemen laut MEDLINE: Apoptosis, Myeloid Cell Leukemia Sequence 1 Protein, TNF-Related Apoptosis-Inducing Ligand, Sesquiterpenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chungnam National University, National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Zerumbone (ZER), a sesquiterpenoid compound extracted from Zingiber zerumbet Smith, exhibits notable anti-proliferative and anti-inflammatory activities. TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) selectively induces apoptosis in tumor cells with minimal impact on normal cells, positioning it as a promising anticancer agent. However, TRAIL resistance remains a major barrier to its clinical effectiveness. In this study, we investigated the synergistic effects of co-treatment with ZER and TRAIL in cancer cells. Our results demonstrated that combined treatment with ZER and TRAIL markedly enhances apoptosis in renal carcinoma cells. ZER treatment induced a decrease in the expression of anti-apoptotic protein Mcl-1, which affected TRAIL-mediated cell death. However, Mcl-1 overexpression attenuated combined treatment-mediated cell death. Furthermore, ZER downregulated the deubiquitinating enzyme USP9x expression level, which plays a key role in Mcl-1 stabilization. Also, overexpression of USP9x prevented combined treatment-induced apoptosis. These findings suggest that ZER increases TRAIL-induced apoptosis by modulating the USP9x-Mcl-1 axis and ZER may serve as a potential strategy to overcome TRAIL resistance in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, South Korea.
- Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, 35015, South Korea. Electronic address: gmhur@cnu.ac.kr.
- Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, South Korea; Center for Forensic Pharmaceutical Science, Keimyung University, Daegu, 42601, South Korea. Electronic address: kwontk@dsmc.o…
Förderung
- Chungnam National University
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Song, S. R., Woo, S. M., Seo, S. U., Jeong, Y. J., Chae, J., Hur, G. M., & Kwon, T. K. (2025). Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152194
Vancouver
Song SR, Woo SM, Seo SU, Jeong YJ, Chae J, Hur GM, et al. Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152194
BibTeX
@article{Song2025,
author = {Song, So Rae and Woo, Seon Min and Seo, Seung Un and Jeong, Yu Jin and Chae, Jongbeom and Hur, Gang Min and Kwon, Taeg Kyu},
title = {Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1},
journal = {Biochemical and Biophysical Research Communications},
year = {2025},
doi = {10.1016/j.bbrc.2025.152194}
}
EUVIMED